Monthly Archives: January 2024

Transforming RSV Prevention: The Role and Challenges of Nirsevimab

This entry is part 2 of 16 in the series Mar 2024

Nirsevimab (Beyfortus) is a significant advancement in the prevention of Respiratory Syncytial Virus (RSV) in infants, providing lasting protection with one dose, but its equitable distribution faces logistical, financial, and systemic hurdles, and necessitates tailored approaches in vulnerable communities like the American Indian or Alaska Native population.

Read more

PHAB Stories of Impact: Amplifying Voices of Accredited Health Departments

This entry is part 44 of 67 in the series Focus on Accreditation and Innovation

Janalle Goosby and Jocelyn Feaster describe PHAB’s Stories of Impact, a series that highlights the real-world outcomes and changes brought about through the PHAB accreditation process and other PHAB tools and resources.

Read more

Lessons Learned from a Narrative Review of Studies Researching the Impact of Law on Health and Economic Outcomes

This entry is part 11 of 11 in the series Jan 2024

Insights from a multidisciplinary team’s review of studies linking law and policy with health and economic outcomes reveal ways to strengthen methods used to conduct health policy research.

Read more
« Older Entries